Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 286,282 shares at $33.30 ($9.9M) on 2021-05-24, disclosed to the SEC on 2021-05-24.
Open-market sale of $9.9M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.80 | 133,359 | $4.6M | 46.6% |
| 2 | $34.80 | 133,359 | $4.6M | 46.6% |
| 3 | $33.30 | 1,563 | $52K | 0.5% |
| 4 | $33.30 | 1,563 | $52K | 0.5% |
| 5 | $34.28 | 8,219 | $282K | 2.8% |
| 6 | $34.28 | 8,219 |
| $282K |
| 2.8% |
| Total | $34.75 avg | 286,282 | $9.9M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |